Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

This publication has 32 references indexed in Scilit:

• Thrombophilia Testing, Recurrent Thrombosis, and Women’s Health
  Circulation, 2014
• Antithrombotic Therapy for VTE Disease
  Chest, 2012
• Predictive Value of Factor V Leiden and Prothrombin G20210A in Adults With Venous Thromboembolism and in Family Members of Those With a Mutation
  JAMA, 2009
• Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry
  Thrombosis Research, 2009
• A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies
  Arthritis Care & Research, 2007
• The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies
  Haematologica, 2007
• Antithrombotic Therapy for Venous Thromboembolic Disease
  Chest, 2004
• A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome
  New England Journal of Medicine, 2003
• Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study
  Blood, 2002
• Prevalence of factor V Leiden mutation in various populations
  Genetic Epidemiology, 1997